Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

Regional Variability in the Use of CT for Patients with Suspected Mild Traumatic Brain Injury

(2014) Won Hyung A. Ryu et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Biokinetic Analysis of Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Severe Traumatic Brain Injury Patient Biofluids

(2011) Gretchen M. Brophy et al.   JOURNAL OF NEUROTRAUMA

Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats

(2010) Ming C. Liu et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Structure and Function of Emergency Care Research Networks: Strengths, Weaknesses, and Challenges

(2009) Linda Papa et al.   ACADEMIC EMERGENCY MEDICINE

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury*

(2009) Linda Papa et al.   CRITICAL CARE MEDICINE

Serum S100B protein in early management of patients after mild traumatic brain injury

(2009) R. Morochovič et al.   EUROPEAN JOURNAL OF NEUROLOGY

A Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans

(2009) Robert Siman et al.   JOURNAL OF NEUROTRAUMA

Estimating Radiation Risk from Computed Tomography Scanning

(2009) Vadim Fayngersh et al.   LUNG

Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: Results using a single (24h) time-point

(2009) Timothy Rainey et al.   RESUSCITATION

Cancer risks from diagnostic radiology

(2008) E J HALL et al.   BRITISH JOURNAL OF RADIOLOGY

MEDICAL RADIATION EXPOSURE IN THE U.S. IN 2006: PRELIMINARY RESULTS

(2008) Fred A. Mettler et al.   HEALTH PHYSICS